MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    CLINICAL AND GENEOLOGICAL FEATURES OF PARKINSON’S DISEASE

    S. Kuranbaeva, S. Kalandarova, A. Umarov, G. Goyibova (Tashkent, Uzbekistan)

    Objective: The initial purpose of the work is to study the clinical and genealogical features of Parkinson's disease. Background: Currently, clinical genetics has a number…
  • 2022 International Congress

    DUtch PARkinson Cohort (DUPARC): Contrast Sensitivity and Retinal Changes in Early Parkinson’s Disease Patients

    C. Gillen, S. Zee, N. Jansonius, T. van Laar (Groningen, Netherlands)

    Objective: To identify and characterize the correlation between static contrast sensitivity (SCS), dynamic contrast sensitivity (DCS), and thickness of the internal plexiform layer (IPL) in…
  • 2022 International Congress

    Long-term safety of continuous levodopa/carbidopa infusion with ND0612: Data from patients who continued past one year in the BeyoND study

    S. Isaacson, N. Giladi, F. Stocchi, L. Salin, N. Vostokova, W. Poewe (Boca Raton, USA)

    Objective: To report long-term safety and tolerability data from the ongoing BeyoND study (NCT02726386) for patients who continued treatment past the one-year primary endpoint. Background:…
  • 2022 International Congress

    Dopamine-independent cortical disinhibition in Parkinson’s disease

    C. Ammann, M. Dileone, C. Pagge, D. Mata-Marín, M. Matarrazzo, M. Monje, A. Sánchez-Ferro, B. Fernández-Rodríguez, C. Gasca-Salas, J. Máñez-Miró, R. Martínez-Fernández, L. Vela, F. Alonso-Frech, A. Oliviero, JA. Obeso, G. Foffani (Móstoles, Spain)

    Objective: To test the hypothesis that cortical disinhibition in Parkinson's disease is a dopamine-independent process. Background: Motor cortex alterations in Parkinson's disease are classically considered…
  • 2022 International Congress

    Cortical and cerebellar excitability in essential tremor

    C. Ammann, C. Pagge, JA. Pineda-Pardo, M. Del álamo, R. Martínez-Fernández, A. Oliviero, JA. Obeso, G. Foffani (Móstoles, Spain)

    Objective: To investigate the functional state of motor cortex excitability and the involvement of the cerebello-thalamo-cortical pathway using transcranial magnetic stimulation (TMS) in patients with…
  • 2022 International Congress

    Delayed post-stroke parkinsonism: description of two cases and possible mechanism

    T. Friedeman- Korn, M. Bauer, M. Abu Snineh, C. Weill, D. Arkadir (Jerusalem, Israel)

    Objective: To present two patients who developed delayed parkinsonism years after experiencing midbrain strokes and to suggest a possible mechanism for this delayed phenomenon. Background:…
  • 2022 International Congress

    THE EFFECT OF DEEP BRAIN STIMULATION ON LOWER URINARY TRACT SYMPTOMS IN PARKINSON’S DISEASE

    P. Araújo, A. Francisco, R. de Fraga, L. Frizon, M. ávila, I. Filho, L. Pancera, G. Schaidt, J. Goginski, A. Farinazzo (Curitiba, Brazil)

    Objective: To evaluate lower urinary tract symptoms between Parkinson’s Disease (PD) patients with and without deep brain stimulation (DBS). Background: Parkinson's disease (PD) is well…
  • 2022 International Congress

    Cognitive and Psychiatric Correlates of Fear of Falling in Progressive Supranuclear Palsy and Multiple System Atrophy

    V. Martinez-Villota, C. Terroba-Chambi Chambi, S. Castillo-Torres, M. Rossi, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate the clinical correlates of fear of falling (FoF) in patients with Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA) Background: FoF…
  • 2022 International Congress

    Dopamine agonist utilization prior to the initiation of device aided therapy: data from 150 patients with advanced Parkinson’s disease treated with Levodopa Carbidopa Intestinal Gel

    J. Szasz, V. Constantin, K. Orban-Kis, L. Bancu, S. Bataga, R. Neagoe, J. Szederjesi, B. Grigorescu, M. Ciorba, I. Mihaly, K. Kelemen, S. Szatmari (Targu Mures, Romania)

    Objective: Objective: To evaluate the usage of dopamine agonists (DA) as part of the last conventional dopaminergic treatment in a large cohort of consecutive patients…
  • 2022 International Congress

    Electrophysiology and clinical description of Tremor in Spinocerebellar Ataxia 12 (SCA12)

    A. Srivastava, M. Narang, R. Rajan, M. Faruq (New Delhi, India)

    Objective: To describe the clinical and electrophysiological characteristics of tremor in SCA12. Background: There is scarcity of literature on tremor of SCA12 patients which is…
  • « Previous Page
  • 1
  • …
  • 108
  • 109
  • 110
  • 111
  • 112
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley